课题基金 / 基金详情

ENALAPRIL/DITIAZEM ER SEVERE HYPERTENSION STUDY

ENALAPRIL/DITIAZEM ER SEVERE HYPERTENSION STUDY
依那普利/地硫卓严重高血压研究
批准号：
3766116
负责人：
EDWARD C. CONRADI
金额：
$0.0万
依托单位：
MEDICAL UNIVERSITY OF SOUTH CAROLINA
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/3766116
关键词：
antihypertensive agents cardiovascular disorder chemotherapy clinical trials combination chemotherapy drug screening /evaluation enalapril human subject human therapy evaluation hypertension

项目摘要

项目成果

EDWARD C. CONRADI的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This open-label, multi-center trial will investigate the hypothesis that enalapril (5 mg) combined with ditiazem ER (120 mg or 180 mg) is safe, well-tolerated, and effective in lowering blood pressure as combination therapy alone or with other antihypertensive therapies in patients with severe hypertension.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ISRADIPINE, ENALAPRIL & ATENOLOL EFFECTS ON ELDERLY FEMALE PATIENTS
DILTIAZEM ER DOSE RESPONSE IN PATIENTS WITH MILD TO MODERATE HYPERTENSION
COMPARING EFFICACY AND TOLERABILITY OF FELODIPINE AND VERAPAMIL
ANTIHYPERTENSIVE EFFICACY AND SAFETY OF DIFFERENT DUP-753 (MK954) DOSES